MorphoSys GmbH, Boehringer Mannheim GmbH deal

The companies agreed to optimize a diagnostic antibody using MorphoSys's Trinucleotide Mutagenesis and synthetic Human Combinatorial Antibody Libraries. Boehringer Mannheim will provide R&D funding an...